BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 30913015)

  • 1. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
    Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
    Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients.
    Battezzati A; Mari A; Zazzeron L; Alicandro G; Claut L; Battezzati PM; Colombo C
    Eur J Endocrinol; 2011 Jul; 165(1):69-76. PubMed ID: 21502328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of glucose area under the curve from the oral glucose tolerance test as a screening tool for cystic fibrosis-related diabetes.
    Gileles-Hillel A; Soesman LH; Miari S; Breuer O; Tsabari R; Elyashar-Earon H; Armoni S; Sprikkelman AB; Reiter J; Zangen D; Lavi E; Kerem E; Cohen-Cymberknoh M
    Pediatr Pulmonol; 2022 Nov; 57(11):2774-2780. PubMed ID: 35999051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
    Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
    Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
    Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
    J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
    Coriati A; Ziai S; Azar M; Berthiaume Y; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
    Merjaneh L; He Q; Long Q; Phillips LS; Stecenko AA
    J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
    Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
    Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
    Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
    Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function.
    Piona C; Volpi S; Zusi C; Mozzillo E; Tosco A; Franzese A; Raia V; Boselli ML; Trombetta M; Cipolli M; Bonadonna RC; Maffeis C
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1793-e1802. PubMed ID: 33331877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
    Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
    Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
    Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
    PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.